Molecular Nutrition

Synthesis of Dihydromyricetin-Nickel Complex and Preliminary Study on Its Cell Toxicity

Expand
  • 1. School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, China;
    2. Guangzhou Tianke Biological Technology Co., Ltd., Guangzhou 510627, China;
    3. College of Zhongkai Agricultural Engineering, Guangzhou 510225, China

Received date: 2018-03-13

  Online published: 2018-09-20

Abstract

This experiment was conducted to synthesis the dihydromyricetin-nickel complex (DMY-Ni) and clarify the feeding safety of DMY-Ni as a feed additive. DMY-Ni was prepared by the heating reflux method with dihydromyricetin (DMY) and nickel acetate as the materials. The complex was characterized by ultraviolet (UV) spectra and infrared (IR) spectra. DMY and DMY-Ni were used to study the effects of different concentrations (10, 20, 40, 80 and 160 μg/mL) and different action time (12, 24, 36 and 48 h) on the proliferation of normal liver parenchymal cells AML12 for mice by MTT method. The results showed as follows:the complex which was synthesized by DMY and nickel ion was confirmed as DMY-Ni. The survival rate of AML12 cells which were treated by 10, 20 and 40 μg/mL DMY or DMY-Ni for 48 h was not significantly different compared with the blank control group (P>0.05). After treatment for 48 h, the survival rate of AML12 cells of DMY-Ni group of 80 μg/mL and above was significantly lower than that of the blank control group (P<0.01 or P<0.001), and the survival rate of AML12 cells of DMY group of 160 μg/mL was significantly lower than that of the blank control group (P<0.01). And the survival rate of AML12 cells was gradually decreased with the increase of the concentration of DMY or DMY-Ni and the extension of the action time. Half the inhibitory concentrations (IC50) of DMY and DMY-Ni on AML12 cells were 285.10 and 222.84 μg/mL, respectively. In conclusion, DMY and DMY-Ni have relatively low toxicity to AML12 cells, and the toxicity to AML12 cells of DMY-Ni is slightly increased compared with DMY.

Cite this article

ZHANG Hui, GUO Qingquan, SHU Xugang, XIE Yu, TAN Wei, LIU Di, ZHANG Ya . Synthesis of Dihydromyricetin-Nickel Complex and Preliminary Study on Its Cell Toxicity[J]. Chinese Journal of Animal Nutrition, 2018 , 30(9) : 3734 -3739 . DOI: 10.3969/j.issn.1006-267x.2018.09.045

References

[1] 张帆.饲料添加剂的开发与安全性检测[J].农业与技术,2015,35(16):182.

[2] 龙海荣,杨洋,刘绍州,等.黄酮类化合物的安全性研究进展[J].食品研究与开发,2008,29(10):154-157.

[3] ZHENG Q K,XU L L,ZHU L H,et al.Preliminary investigations of antioxidation of dihydromyricetin in polymers[J].Bulletin of Materials Science,2010,33(3):273-275.  

[4] XU Y,WANG F,WANG L,et al.Sensitive voltammetric sensor of dihydromyricetin based on Nafion/SWNT-modified glassy carbon electrode[J].Journal of Solid State Electrochemistry,2012,16(4):1473-1480.  

[5] 袁娟,郭清泉,曾金华,等.二氢杨梅素-锌配合物的合成及其与DNA相互作用研究[J].分析测试学报,2012,31(8):982-986.

[6] 郭清泉,林淑英,李大光,等.铁-二氢杨梅素螯合物的制备及抗氧化活性研究[J].食品工业科技,2006,27(1):166-168.

[7] 袁娟.二氢杨梅素的提取、金属离子配合物的制备及其生理活性的研究[D].硕士学位论文.广州:广东工业大学,2013.

[8] 刘艳红,李驰荣,乔丹丹,等.二氢杨梅素结构及剂型修饰的研究进展[J].日用化学工业,2015,45(9):518-522.

[9] 李海霞.二氢杨梅素-镍配合物的制备及其羟自由基的清除作用[J].中国酿造,2013,32(5):70-73.

[10] NGUYEN A T,MALONNE H,DUEZ P,et al.Cytotoxic constituents from Plumbago zeylanica[J].Fitoterapia,2004,75(5):500-504.  

[11] 周防震,郑小江,张晓元.藤茶活性成分二氢杨梅素对人胚肾细胞和肝细胞增殖的影响[J].中成药,2015,37(12):2756-2758.

[12] 舒洋.二氢杨梅素对肝癌细胞增殖、凋亡的作用及机制研究[D].硕士学位论文.广州:广东医学院,2015.

[13] 苏东林,黄继红,姚茂君.二氢杨梅素的急性毒理学评价及对酒精性肝损伤的防治效果[J].湖南农业科学,2009(11):90-93.

[14] 刘丹丹,方宁烨,肖德强,等.茶多酚对体外培养人胚肝细胞生存率的影响[J].广西医学,2013,35(3):260-263.

[15] 张国营,孙玉萍.茶多酚对人胚肺细胞和猴肾细胞毒性的实验研究[J].安徽农业大学学报,1994(4):454-457.

[16] 周美锋,何其庄,费菲.纳米稀土谷氨酸咪唑三元配合物的合成、表征及抗菌活性研究[J].中国稀土学报,2007,25(5):549-555.
Outlines

/